Lv5
1070 积分 2023-06-27 加入
Fragment-to-Lead Medicinal Chemistry Publications in 2024: A Tenth Annual Perspective
2天前
已完结
Deep-Learning-Driven Discovery of SN3–1, a Potent NLRP3 Inhibitor with Therapeutic Potential for Inflammatory Diseases
3天前
已完结
Crystal Structure of NLRP3 NACHT Domain With an Inhibitor Defines Mechanism of Inflammasome Inhibition
3天前
已完结
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
3天前
已完结
Evolving Experimental Techniques for Structure-Based Drug Design
9天前
已完结
The current role and evolution of X-ray crystallography in drug discovery and development
10天前
已完结
INHIBITORS OF HIV-1 PROTEASE: A Major Success of Structure-Assisted Drug Design
1个月前
已完结
Advancements in protein structure prediction: A comparative overview of AlphaFold and its derivatives
1个月前
已完结
An update for AlphaFold3 versus experimental structures: assessing the precision of small molecule binding in GPCRs
1个月前
已完结
Synthesis, EGFR and VEGFR-2 inhibitors, crystal structure, DFT analysis, molecular docking study of β-enaminonitrile incorporating 1H-benzo[f]-chromene-2-carbonitrile
1个月前
已完结
皖公网安备34019202002308
